Christopher Mills - Bioquell plc Insider

BIQLF -- USA Stock  

USD 7.18  0.00  0.00%

  Director
Mr. Christopher Harwood Bernard Mills is an Independent NonExecutive Director of Bioquell PLC., since December 18, 2012. He Joined the Board in December 2012. He is Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust PLC, a director of Oryx International Growth Fund Ltd and is the Chief Investment Officer and a member of Harwood Capital LLP.
Age: 63  Director Since 2012      
44 1264 835 835  http://www.bioquellplc.com
Mills is also a director of Sunlink Health Systems Inc, Bionostics Holdings Limited, Hampton Investment Properties, Second London American Trust PLC, Glass America, Inc, Progeny, Inc, Global Options, Celsis International Limited and MJ Gleeson PLC.

Christopher Mills Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.36 % which means that it generated profit of $6.36 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 12.0 % meaning that it generated $12.0 on every $100 dollars invested by stockholders.

Similar Executives

Showing few of many executives

DIRECTOR Since

Arani BosePenumbra
2015
Shirley JacksonMedtronic plc
2002
Richard AndersonMedtronic plc
2015
Ronica WangGN Store Nord AS
2015
Steven LorangerEdwards Lifesciences Corporatio
2016
Nancy McKinstryAbbott Laboratories
2011
Charles DockendorffBoston Scientific Corporation
2015
Bridget ORourkePenumbra
2017
Robert PozenMedtronic plc
2004
Roxanne AustinAbbott Laboratories
2000
Daniel LemaitreGlobus Medical
2011
Glenn TiltonAbbott Laboratories
2007
Nicholas ValerianiEdwards Lifesciences Corporatio
2014
Alison DeansCochlear Limited
2015
John CardisEdwards Lifesciences Corporatio
2004
David DavidarGlobus Medical
2016
Nelda ConnorsBoston Scientific Corporation
2009
Ernest MarioBoston Scientific Corporation
N/A
Barbara McNeilEdwards Lifesciences Corporatio
2006
Gregory SantoraAlign Technology
2003
Wolfgang ReimGN Store Nord AS
2008

Entity Summary

Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and traded on OTC Market. It employs 220 people.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 220 people.

Bioquell plc Leadership Team

Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director
Simon Constantine, Independent Non-Executive Director

Stock Performance Indicators

Current Sentiment - BIQLF

Bioquell plc Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in Bioquell plc. What is your opinion about investing in Bioquell plc? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Bioquell plc Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bioquell plc and Medtronic plc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.
Search macroaxis.com